Diana Marcela Perea Rojas

Dr. Diana Marcela Perea Rojas

Universidad Simón Bolívar, Barranquilla, Atlántico, Colombia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in Case Reports in Nephrology
Verified
Journal Article
Open access
JMJaime Arturo Dulce Muñóz
Jaime Arturo Dulce Muñóz
GAGustavo Aroca
Gustavo Aroca
CHChristian David Seni Hernández
Christian David Seni Hernández
DRDiana Marcela Perea Rojas
Diana Marcela Perea Rojas
OBOmar Cabarcas Barbosa
Omar Cabarcas Barbosa
ITIndiana Luz Rojas Torres
Indiana Luz Rojas Torres
Systemic lupus erythematosus is a systemic autoimmune pathology that generally presents in young people and manifests acutely, while its late presentation in people over 50 years of age is rare and insidious. Vasculitis is a pathology that affects any vessel producing fibrinoid necrosis, and presents with a positive antineutrophil cytoplasmic antibody. The concomitance of these two entities is rare and leads to worse clinical outcomes. We present a 73-year-old female patient who presented with rapidly progressive glomerulonephritis requiring renal replacement therapy, pulmonary tuberculosis, late-onset lupus erythematosus with lupus nephritis, and a positive result for neutrophil cytoplasmic antibody. An immune-mediated extracapillary proliferative glomerulonephritis was found when the biopsy was performed, with obvious signs of vasculitis, an overlap syndrome was found between these entities. She was initially treated with antituberculosis therapy, boluses of methylprednisolone and continued with intermittent renal replacement therapy; however, due to the severity of his pathologies, she had a fatal outcome. The concomitance between these autoimmune pathologies is unusual; there is a late-onset overlap syndrome between lupus nephritis accompanied by myeloperoxidase-antineutrophil cytoplasmic antibody and pauci-immune glomerulonephritis. The dual presentation establishes clinical challenges for its diagnosis as well as the initiation of immunosuppressive therapy when there are additional infectious pathologies.

1 August 2024 in Journal of Medical Cases
Verified
Journal Article
Open access
PDF file
DRDiana Marcela Perea Rojas
Diana Marcela Perea Rojas
CHChristian David Seni Hernandez
Christian David Seni Hernandez
ITIndiana Luz Rojas Torres
Indiana Luz Rojas Torres
MOMarianela Olivares Olmos
Marianela Olivares Olmos
CJCamila Maria Garcia Jarava
Camila Maria Garcia Jarava
SCSilvia Salva Camano
Silvia Salva Camano
Peripartum Cardiomyopathy: A Case Report of Mortality From a Rare and Potentially Fatal Condition

2 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ILIvan David Lozada-Martinez
Ivan David Lozada-Martinez
LALuis Miguel Delgado Arias
Luis Miguel Delgado Arias
DRDiana Marcela Perea Rojas
Diana Marcela Perea Rojas
ITIndiana Luz Rojas Torres
Indiana Luz Rojas Torres
Despite the exponential expansion of neuroscience over recent decades, the field has rarely examined the rigor, transparency, and reproducibility of its own evidence base (research on research). Through a brief systematic exploration of the Scopus database, we identified more than 370,000 neuroscience articles, yet only 15 explicitly addressed meta-research questions, representing a mere 0.004% of the total literature. These few studies were concentrated in high-income countries and limited mainly to neuroimaging and methodological reporting, leaving major subfields such as neuropharmacology, neuropathology, and neuroendocrinology virtually unexplored. This striking imbalance reveals a systemic absence of evidence self-assessment and highlights how neuroscience has advanced without adequate reflection on the validity and translatability of its findings. The lack of meta-research weakens the reliability of neuroscientific evidence, slows the development of shared reporting standards, and risks compromising its translation into evidence-based neurological practice. Strengthening global collaboration, fostering reflexivity, and integrating meta-research into neuroscience are urgent steps toward ensuring that the knowledge generated in laboratories and trials truly supports trustworthy, reproducible, and clinically meaningful clinical healthcare in neurological sciences.

ITIndiana Luz Rojas Torres
Indiana Luz Rojas Torres
CDClaudia Milena Garizábalo Dávila
Claudia Milena Garizábalo Dávila
KGKEIDIS SULAY RUIDIAZ GOMEZ
KEIDIS SULAY RUIDIAZ GOMEZ
SASHIRLEY PAOLA FERNANDEZ ARAGON
SHIRLEY PAOLA FERNANDEZ ARAGON
DRDiana Marcela Perea Rojas
Diana Marcela Perea Rojas
NMNorma Isabel Liñán Meléndez
Norma Isabel Liñán Meléndez
Health behavior encompasses the attitudes, decisions, and actions that individuals adopt in their daily lives and that directly influence their well-being. The objective of this study was to evaluate the effectiveness of a nursing intervention based on Nola Pender’s Health Promotion Model in promoting healthy behaviors among adults over 20 years of age. A quasi-experimental design was used with a sample of adults from a Colombian community. In 2022, sociodemographic data were collected, and the Health-Promoting Lifestyle Profile II (HPLP-II), developed by Nola Pender to measure healthy lifestyles, was administered. In 2023, the intervention was carried out in 24 group sessions of 40 min each, supported by printed educational material and focused on the dimensions of Pender’s theory. Statistical analysis using nonparametric tests such as the Mann–Whitney U and Kruskal–Wallis tests showed significant improvements: the overall score increased from 22.92 in the pre-test to 27.30 in the post-test. The physical activity dimension received the lowest score, while the spiritual growth dimension showed the highest improvement. The results indicate that nursing interventions based on Pender’s model led to statistically significant improvements in multiple dimensions of healthy behavior, with the greatest impact on spiritual growth and health responsibility.

5 September 2025 in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
Verified
Journal Article
Open access
PDF file
GAGustavo Aroca
Gustavo Aroca
VJValentina Pérez Jiménez
Valentina Pérez Jiménez
MSMaría Raad Sarabia
María Raad Sarabia
DRDiana Marcela Perea Rojas
Diana Marcela Perea Rojas
CMCarlos G. Musso
Carlos G. Musso
AGAntonio Iglesias Gamarra
Antonio Iglesias Gamarra
Introduction: Late-onset systemic lupus erythematosus (SLE) is a rare form of the disease, characterized by atypical clinical manifestations and a higher burden of comorbidities, which makes it challenging to diagnose and manage on time. The objective of this study was to compare the sociodemographic, clinical, and paraclinical characteristics, as well as the therapeutic outcomes, of patients with early- and late-onset SLE in a reference center in the Colombian Caribbean. Methods: Observational, descriptive, and cross-sectional study, based on the review of medical records from the RENELUP database (2010–2024). Patients aged ≥18 years who met the 2019 EULAR/ACR criteria were included. Chi-square, Fisher's, and Student's T tests were applied. Results: A total of 282 patients were analyzed: 235 (83%) with early SLE and 47 (17%) with late SLE. Females predominated (89% and 81%, respectively). Late SLE had higher proteinuria (2,900 vs 662 mg/24h; P<0.001) and lower HDL (41 vs 48 mg/dl; P=0.038). There were no significant differences in remission or mortality, although mortality was higher in late SLE (20.7% vs 10.1%). Conclusion: Patients with late SLE had a lower frequency of typical clinical manifestations, including mucocutaneous, joint, and hematological involvement. In terms of renal involvement, patients with late SLE had a higher burden of proteinuria, with no statistically significant differences in mortality or remission rate.

4 March 2026 in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
Verified
Journal Article
Open access
Jorge Rico FontalvoJorge Rico Fontalvo
Jorge Rico Fontalvo
GAGustavo Aroca
Gustavo Aroca
VJValentina Pérez Jiménez
Valentina Pérez Jiménez
MVMaría De Los Ángeles Vélez Verbel
María De Los Ángeles Vélez Verbel
ABAndrés Cadena Bonfanti
Andrés Cadena Bonfanti
RDRodrigo Daza-Arnedo
Rodrigo Daza-Arnedo
Introduction: Systemic lupus erythematosus is a systemic autoimmune disease that can affect multiple organs, including vascular structures, although this involvement is uncommon. Leukocytoclastic vasculitis is a rare form of small-vessel vasculitis characterized by inflammation of dermal venules and manifests clinically as palpable purpura. Its association with myocarditis, hypertension, and lupus nephritis is uncommon and presents a diagnostic and therapeutic challenge. Case Report: We present the case of a 53-year-old female patient who consulted for purpuric lesions on her lower extremities, pretibial edema, and joint symptoms. Her condition was complicated by severe hypertension, myocarditis, and lupus nephritis. Skin and kidney biopsies confirmed the diagnoses of leukocytoclastic vasculitis and lupus nephritis, respectively. Outcome: The patient was treated with intravenous methylprednisolone, followed by prednisolone, with significant improvement in clinical manifestations and laboratory parameters. Conclusion: This case highlights the diverse presentations of SLE, particularly its association with leukocytoclastic vasculitis, a rare but relevant manifestation. Early management with immunosuppressants led to a favorable clinical outcome. This report underscores the importance of suspecting SLE in patients with atypical vasculitis and of adopting a multidisciplinary approach to achieve timely diagnosis and treatment.